Highlights and Quick Summary
- Cash and Short Term Investments for the quarter ending September 30, 2022 was $85.7 Million (a -15.73% decrease compared to previous quarter)
- Year-over-year quarterly Cash and Short Term Investments decreased by -26.75%
- Annual Cash and Short Term Investments for 2021 was $117 Million (a -51.25% decrease from previous year)
- Annual Cash and Short Term Investments for 2020 was $240 Million (a 39.09% increase from previous year)
- Annual Cash and Short Term Investments for 2019 was $173 Million (a 50.75% increase from previous year)
Visit stockrow.com/BCEL
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Cash and Short Term Investments of Atreca, Inc.
Most recent Cash and Short Term Investmentsof BCEL including historical data for past 10 years.Interactive Chart of Cash and Short Term Investments of Atreca, Inc.
Atreca, Inc. Cash and Short Term Investments for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $85.73 | $101.73 | $117.9 | – |
| 2021 | $117.03 | $152.89 | $182.31 | $211.67 | $117.03 |
| 2020 | $240.09 | $259.26 | $143.52 | $151.06 | $240.09 |
| 2019 | – | $172.62 | $201.04 | $219.66 | $172.62 |
| 2018 | – | – | – | $114.5 | $114.5 |
| 2017 | – | – | – | – | $30.61 |
Business Profile of Atreca, Inc.
Sector: Healthcare
Industry: Biotechnology